Hypothesis: Platelet-activating factor (PAF) activates p38, an important in
tracellular signal transduction kinase, and primes human mononuclear cells
for the production of interleukin 8 (IL-8), a potent chemoattractant and ac
tivator of neutrophils.
Methods: Human mononuclear cells were isolated from healthy adults by Ficol
l-paque density-gradient centrifugation. Interleukin-8 in the supernatant w
as measured by enzyme-linked immunosorbent assay. Dual phospho-specific p38
antibody was used to detect activated p38 by Western blotting.
Results: Lipopolysaccharide (LPS) and PAF activated p38. There was a shorte
r latency to peak p38 activation with PAF vs LPS stimulation, 5 vs 30 minut
es. Platelet-activating factor-induced p38 activation was calcium dependent
because it was inhibited by ethyleneglycoltetracetic acid. Lipopolysacchar
ide. 0.01 to 1.00 ng/mL, induced significant IL-8 production. Although PAF
did not induce significant IL-8 production, it potentiated LPS-induced IL-8
production. Production of IL-8, in response to LPS alone or in combination
with PBF, was inhibited by SB202190, a specific p38 inhibitor.
Conclusions: Although LPS and PAF activated p38, only LPS induced IL-8 prod
uction; PAF acted as a priming agent. It seems that p38 activation is neces
sary but not sufficient for IL-8 production by human mononuclear cells. Ide
ntifying and evaluating the activation state of inflammatory signal transdu
ction pathways might lead to methods for controlling and preventing neutrop
hil-induced tissue injury without interfering with the normal host immune r
esponse.